Interventional Radiology Market Size, Share, Growth, and Industry Analysis, By Type (MRI Systems,Ultrasound Imaging Systems,CT Scanners,Angiography Systems,Fluoroscopy Systems,Biopsy Devices,OthersS), By Application (Angiography,Balloon Angioplasty,Embolization,Biopsy,Vertebroplasty-Kyphoplasty,RF Ablation), Regional Insights and Forecast to 2035

Interventional Radiology Market Overview

The global Interventional Radiology Market size is projected to grow from USD 25074.03 million in 2026 to USD 28248.4 million in 2027, reaching USD 73308.09 million by 2035, expanding at a CAGR of 12.66% during the forecast period.

The market is gaining momentum as over 80% of hospitals worldwide now use image-guided procedures, with approximately 25 million interventional radiology treatments performed annually across cardiology, oncology, and neurology. Rising demand for minimally invasive techniques has led to a 45% reduction in hospital stays compared to open surgery, making interventional radiology a cornerstone of modern medical care.

The industry report highlights that more than 65% of procedures rely on ultrasound and CT-guided systems, ensuring enhanced precision and safety. With an estimated 10% annual increase in demand for catheter-based therapies, interventional radiology is also driving down procedure-related mortality rates by nearly 30%. Market insights show that the integration of AI-assisted imaging is projected to support faster decision-making and improve outcomes for over 70% of high-risk patients by 2030.

Future market outlook suggests strong opportunities in AI-powered diagnostics, robotic-assisted navigation, and portable imaging systems. By 2033, over 60% of hospitals are expected to adopt robotic interventional suites, while mobile imaging devices will account for nearly 40% of new installations. Such market opportunities position interventional radiology at the center of global healthcare transformation, offering safer, quicker, and more cost-effective solutions.

The USA interventional radiology market accounts for nearly 38% of global adoption, with over 9,500 hospitals and clinics offering interventional procedures. Each year, more than 12 million image-guided procedures are performed across the country, including angioplasty, embolization, and tumor ablation. In fact, nearly 72% of U.S. cardiovascular surgeries are now minimally invasive, supported by advanced fluoroscopy and ultrasound systems. Government data shows that the U.S. spends approximately USD 4.3 trillion annually on healthcare, and interventional radiology contributes significantly to reducing surgical costs by nearly 25% per patient.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 78% of hospitals prefer minimally invasive procedures, 65% reduction in patient recovery time, and 52% decline in surgery-related infections.
• Major Market Restraint: 41% of regions face high device costs, 36% shortage of skilled radiologists, and 29% report limited reimbursement policies.
• Emerging Trends: 62% increase in AI-based imaging adoption, 47% rise in robotic-assisted procedures, and 55% surge in outpatient interventional radiology centers.
• Regional Leadership: North America holds 38% share, Europe 28%, Asia-Pacific 22%, and Middle East & Africa 12% of global procedures.
• Competitive Landscape: 33% share held by top 5 companies, 28% rise in M&A activities, and 46% of new launches driven by U.S.-based players.
• Market Segmentation: 54% share from diagnostic imaging, 32% from therapeutic applications, and 14% from hybrid systems.
• Recent Development: 49% increase in FDA approvals in the last 3 years, 35% investment in robotic imaging, and 27% expansion of portable radiology systems.

Interventional Radiology Market Trends

The interventional radiology market is experiencing rapid transformation with over 30 million minimally invasive procedures conducted globally every year. Trends highlight a 55% rise in hybrid imaging centers, where MRI, ultrasound, and CT-guided therapies are integrated under one roof. Another strong market trend is the adoption of AI algorithms, which now assist in nearly 45% of diagnostic imaging workflows. Industry analysis indicates that robotic-assisted interventions have grown by 50% since 2020, with demand for precision oncology treatments growing at 20% annually.

Interventional Radiology Market Dynamics

The global market dynamics are shaped by increasing demand for minimally invasive therapies, technological advancements, and growing patient awareness. Each year, more than 22 million cancer patients undergo diagnostic imaging, and nearly 60% benefit from interventional procedures like tumor embolization and biopsy. Market drivers include 72% patient preference for outpatient treatments and 65% hospital preference for reducing average length of stay. On the restraint side, high costs and lack of radiologists impact adoption in nearly 40% of low-income countries.

DRIVER

"Growing adoption of minimally invasive therapies is the key market driver."

Over 78% of hospitals worldwide now prefer minimally invasive procedures due to their ability to reduce hospital stays by 45% and cut post-surgery complications by 30%. Patient surveys indicate that 67% choose image-guided therapies over open surgeries due to faster recovery and reduced pain. Global market analysis shows that interventional radiology procedures such as angioplasty, embolization, and tumor ablation contribute to saving nearly 2.5 million lives annually by lowering surgical risks.

RESTRAINT

"High equipment cost and shortage of skilled professionals act as restraints."

Approximately 41% of low and middle-income countries face barriers to adopting advanced interventional radiology systems due to equipment prices averaging 25% higher than conventional surgical devices. Moreover, industry research reports reveal that 36% of hospitals globally face a shortage of trained interventional radiologists, limiting widespread adoption. In rural regions, more than 29% of healthcare centers still lack access to modern imaging infrastructure such as MRI and CT-guided systems.

OPPORTUNITY

"Artificial intelligence and robotic-assisted interventions offer significant opportunities."

AI integration in diagnostic imaging has grown by 62% in the last five years, enabling radiologists to achieve up to 45% faster diagnosis and 30% higher accuracy. Robotic-assisted interventional procedures are expected to account for 40% of all interventional radiology treatments by 2033, significantly improving surgical precision. Market insights reveal that nearly 70% of hospitals plan to integrate AI-powered imaging analytics into their radiology departments by 2030. Furthermore, 48% of healthcare organizations are investing in robotic navigation systems, expanding opportunities in vascular and oncology-related interventions.

CHALLENGE

"Regulatory compliance and training remain the biggest challenges for market growth."

More than 44% of interventional radiology companies cite regulatory approval delays as a primary barrier to market entry, with average approval times extending beyond 24 months. Additionally, only 58% of hospitals worldwide have fully trained interventional radiology teams, creating a shortage of skilled professionals. In emerging markets, 32% of healthcare providers face difficulty integrating advanced imaging platforms due to outdated infrastructure. Reports indicate that 26% of devices encounter compliance issues related to radiation safety and clinical trial requirements.

Interventional Radiology Market Segmentation

The market is segmented by type, application, and end-use, with each category contributing significantly to overall adoption. Diagnostic imaging accounts for 54% of the market, therapeutic applications for 32%, and hybrid solutions for 14%. Reports highlight that angiography is the most widely used application, covering 42% of procedures, followed by balloon angioplasty at 28%. On the technology side, MRI and ultrasound systems dominate the global market with 65% usage share due to their precision and non-invasive approach.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

MRI Systems: MRI systems account for over 38% of interventional radiology procedures globally. With approximately 45,000 MRI units installed worldwide, the technology is essential for guiding soft tissue interventions, brain imaging, and vascular mapping. Studies show that MRI-guided therapies reduce procedural complications by 33% compared to conventional methods. The U.S. leads with 12,000 MRI units, while Japan and Germany together account for 9,000 installations.

The MRI systems segment of the interventional radiology market holds a market size of USD 7.8 billion, accounting for 42% share, and is growing at a CAGR of 6.9%. Increasing neurological, cardiovascular, and oncology cases are fueling demand along with advanced imaging technologies.

Top 5 Major Dominant Countries in the MRI Systems Segment

• United States: Market size USD 2.5 billion, 32% share, CAGR 7.0%. Demand is supported by high healthcare spending, advanced hospital infrastructure, and rapid adoption of AI-enabled imaging. U.S. healthcare providers leverage MRI in neurology and cardiology, sustaining dominance in diagnostic and interventional procedures consistently.
• Germany: Market size USD 1.1 billion, 14% share, CAGR 6.8%. Strong diagnostic imaging infrastructure, oncology demand, and cardiovascular programs drive MRI utilization. Germany’s precision medicine initiatives and strong presence of global imaging manufacturers maintain consistent growth in MRI-based interventional applications effectively.
• Japan: Market size USD 950 million, 12% share, CAGR 6.9%. High elderly population and increasing cancer prevalence support MRI system expansion. Japan’s advancements in high-resolution and portable imaging technologies foster strong demand across hospitals and specialized diagnostic centers sustainably.
• China: Market size USD 900 million, 11% share, CAGR 7.2%. Growing hospital capacity, government reforms, and domestic MRI production strengthen adoption. Rising focus on early cancer detection and neurological imaging enhances China’s expansion within interventional radiology segments significantly.
• United Kingdom: Market size USD 780 million, 10% share, CAGR 6.7%. NHS modernization, oncology screening programs, and cardiovascular procedures fuel MRI growth. Integration of digital imaging systems and AI-supported diagnostics enhance utilization, ensuring long-term growth momentum considerably.

Ultrasound Imaging Systems: Ultrasound systems represent nearly 27% of interventional radiology applications. With over 1.7 million ultrasound-guided biopsies performed annually, the technology remains the most accessible imaging modality. Reports show that 68% of rural hospitals prefer ultrasound due to its affordability and portability. Real-time imaging capabilities have improved procedural success rates by 40%, especially in liver and kidney treatments.

The ultrasound imaging systems segment stands at USD 6.5 billion, capturing a 35% share, with a CAGR of 6.5%. Growth is driven by demand for minimally invasive procedures, cost efficiency, and broad adoption in cardiovascular, urology, and abdominal interventions.

Top 5 Major Dominant Countries in the Ultrasound Imaging Systems Segment

• United States: Market size USD 1.9 billion, 29% share, CAGR 6.6%. Ultrasound is widely adopted in emergency care, cardiology, and minimally invasive interventions. Technological innovations in 3D/4D imaging and AI-assisted diagnostics are supporting market expansion consistently across healthcare facilities.
• China: Market size USD 1.4 billion, 22% share, CAGR 6.7%. Rapid urban healthcare expansion, increasing cancer detection programs, and strong local manufacturing drive adoption. Rising preference for non-invasive diagnostics supports long-term ultrasound growth across regional and tertiary hospitals.
• India: Market size USD 900 million, 14% share, CAGR 6.8%. Growth is driven by government healthcare programs, expanding hospital infrastructure, and prenatal diagnostic demand. Increasing affordability of portable ultrasound systems enhances rural and semi-urban healthcare access progressively.
• Germany: Market size USD 750 million, 12% share, CAGR 6.4%. Adoption in cardiovascular and abdominal imaging procedures is rising. Government-backed digitalization in hospitals and high demand for early-stage cancer detection strengthen Germany’s ultrasound market considerably.
• Japan: Market size USD 650 million, 10% share, CAGR 6.3%. Elderly patient base and innovative portable imaging technologies drive adoption. Focus on cardiovascular care and oncology diagnostics ensures steady utilization across both public and private medical institutions.

BY APPLICATION

Angiography: Angiography is one of the most dominant applications in the interventional radiology market, accounting for nearly 42% of total procedures worldwide. Each year, over 7 million angiography procedures are performed globally to diagnose and treat vascular disorders. The U.S. alone records more than 1.5 million angiography tests annually, driven by the rising prevalence of cardiovascular diseases affecting nearly 48% of adults.

The angiography segment of the interventional radiology market holds USD 8.3 billion, representing a 44% share, with a CAGR of 7.1%. Strong demand is driven by cardiovascular disease prevalence and advanced catheter-based procedures worldwide.

Top 5 Major Dominant Countries in the Angiography Segment

• United States: Market size USD 2.7 billion, 32% share, CAGR 7.3%. Cardiovascular disease burden and high interventional procedure rates fuel growth. AI-assisted angiography and minimally invasive procedures drive continuous market leadership in both hospitals and specialized centers.
• China: Market size USD 1.5 billion, 18% share, CAGR 7.2%. Cardiovascular programs, government reforms, and hospital expansion sustain demand. Adoption of advanced angiography systems improves procedural efficiency and enhances patient outcomes effectively.
• Germany: Market size USD 1.1 billion, 13% share, CAGR 7.0%. High rates of cardiovascular procedures and oncology-driven imaging strengthen adoption. Germany’s strong hospital infrastructure and advanced healthcare integration ensure consistent utilization of angiography technologies sustainably.
• Japan: Market size USD 950 million, 11% share, CAGR 6.9%. Aging population and rising cardiovascular cases accelerate adoption. Japan’s strong innovation pipeline in catheter-based imaging supports robust angiography market growth steadily.
• India: Market size USD 850 million, 10% share, CAGR 7.4%. Rising cardiac intervention needs, hospital modernization, and increasing affordability drive demand. India’s adoption of digital angiography technologies strengthens its expansion considerably.

Balloon Angioplasty: Balloon angioplasty represents around 28% of interventional radiology procedures and remains a critical treatment for blocked arteries. Globally, more than 4 million balloon angioplasty procedures are carried out annually, with the U.S. performing nearly 1.2 million cases every year. Clinical studies show that balloon angioplasty reduces hospital stay duration by 50% compared to bypass surgery, saving healthcare systems significant costs.

The balloon angioplasty segment is valued at USD 7.1 billion, accounting for 38% share, and grows at a CAGR of 6.9%. The demand is supported by rising cardiovascular treatments, minimally invasive surgery preferences, and expansion of interventional cardiology.

Top 5 Major Dominant Countries in the Balloon Angioplasty Segment

• United States: Market size USD 2.2 billion, 31% share, CAGR 7.0%. High cardiovascular disease prevalence, well-developed healthcare infrastructure, and strong insurance coverage sustain growth. U.S. leadership is anchored by innovation in stents and catheters.
• China: Market size USD 1.2 billion, 17% share, CAGR 7.2%. Government reforms, cardiovascular programs, and healthcare modernization fuel adoption. Expanding access to advanced angioplasty tools improves clinical efficiency considerably.
• Germany: Market size USD 950 million, 13% share, CAGR 6.8%. Advanced interventional cardiology programs and strong R&D enhance balloon angioplasty adoption. Germany remains a key hub for Europe’s interventional cardiovascular therapies consistently.
• Japan: Market size USD 870 million, 12% share, CAGR 6.7%. Elderly demographics and growing cardiovascular interventions support growth. Japan’s medical device advancements drive reliable demand in hospitals and cardiac centers.
• India: Market size USD 760 million, 11% share, CAGR 6.9%. Expanding cardiac intervention programs, affordable healthcare reforms, and increasing medical tourism boost angioplasty adoption steadily.

Regional Outlook of the Interventional Radiology Market

The global market is regionally segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa, each contributing unique strengths and challenges. North America leads with a 38% market share, driven by strong healthcare infrastructure and technological advancements. Europe follows with 28%, supported by universal healthcare systems and high adoption of advanced imaging. Asia-Pacific contributes 22% and is the fastest-growing region, fueled by rising chronic disease prevalence and healthcare investments. The Middle East & Africa account for 12%, with gradual growth tied to expanding healthcare access.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the global interventional radiology market with nearly 38% share, supported by over 9,500 hospitals and advanced research centers. The U.S. alone performs more than 12 million minimally invasive image-guided procedures annually, including angioplasty, embolization, and tumor ablation. Canada contributes significantly with a strong cancer screening network, where nearly 60% of oncology patients undergo image-guided interventions. Reports highlight that 72% of cardiovascular surgeries in the U.S. are now minimally invasive. With an aging population — projected to reach 95 million people above 65 years by 2060 — demand for interventional radiology is set to surge. The region also leads in technological adoption, with AI-assisted imaging platforms deployed in more than 1,200 hospitals.

The North America interventional radiology market is valued at USD 9.6 billion, holding a 35% global share, and grows at a CAGR of 6.9%. Strong demand comes from cardiovascular disease prevalence, oncology treatments, AI-enabled imaging solutions, and advanced infrastructure, positioning the region as a global innovation leader.

Top 5 Major Dominant Countries in the North America Interventional Radiology Market

• United States: Market size USD 6.2 billion, 65% share, CAGR 7.0%. The U.S. dominates with strong healthcare spending, advanced oncology programs, and AI-driven imaging systems. Extensive hospital networks and cutting-edge innovations support widespread interventional radiology adoption across cardiology and neurology consistently.
• Canada: Market size USD 1.2 billion, 12% share, CAGR 6.8%. Canada benefits from oncology expansion, cardiology programs, and rising cancer screenings. Digital health integration and government-backed infrastructure reforms enhance the adoption of interventional procedures while improving healthcare accessibility steadily.
• Mexico: Market size USD 950 million, 10% share, CAGR 6.7%. Demand is driven by cardiovascular interventions, expanding oncology care, and government investments in hospital upgrades. Increasing private sector involvement supports broader interventional radiology adoption nationwide.
• Brazil: Market size USD 800 million, 8% share, CAGR 6.6%. Brazil leverages oncology treatment programs, cardiovascular health initiatives, and federal healthcare modernization. Strategic investments in advanced diagnostic imaging ensure steady demand across major urban hospitals significantly.
• Argentina: Market size USD 650 million, 6% share, CAGR 6.5%. Growth is supported by healthcare reforms, rising cancer incidence, and expanded cardiology interventions. Argentina’s strong adoption of digital imaging supports increased utilization consistently.

EUROPE

Europe accounts for 28% of the global market share, with Germany, France, and the UK as key contributors. The region performs nearly 8 million interventional radiology procedures annually, with cardiovascular disease impacting more than 85 million Europeans. Reports indicate that over 68% of hospitals in Europe utilize ultrasound-guided systems for diagnostics and interventions. Germany leads the region with more than 2.3 million angiography and balloon angioplasty procedures annually. France reports strong adoption of MRI-guided interventions, while the UK is expanding portable imaging solutions in rural hospitals.

The Europe interventional radiology market is valued at USD 8.8 billion, capturing a 32% share, and expands at a CAGR of 6.7%. Growth is fueled by oncology procedures, high prevalence of cardiovascular diseases, and widespread integration of digital imaging systems across advanced hospital networks.

Top 5 Major Dominant Countries in the Europe Interventional Radiology Market

• Germany: Market size USD 3.0 billion, 34% share, CAGR 6.8%. Strong oncology screening programs and advanced cardiology procedures anchor Germany’s leadership. Integration of AI-enabled imaging and robust R&D pipelines further strengthen adoption across leading hospitals consistently.
• France: Market size USD 2.1 billion, 24% share, CAGR 6.7%. France benefits from cardiovascular treatment expansion, cancer prevalence, and technological integration. Nationwide health programs and oncology reforms drive strong demand across interventional radiology practices progressively.
• United Kingdom: Market size USD 1.8 billion, 20% share, CAGR 6.6%. NHS investments, cardiovascular procedures, and cancer programs sustain demand. The UK leads Europe in adoption of AI-assisted diagnostic imaging significantly.
• Italy: Market size USD 1.0 billion, 11% share, CAGR 6.5%. Growth is fueled by oncology expansion, cardiology services, and modernized hospitals. Government support for advanced imaging accelerates adoption gradually.
• Spain: Market size USD 900 million, 10% share, CAGR 6.4%. Rising cancer treatments, cardiovascular procedures, and strong hospital capacity sustain Spain’s adoption. Technological upgrades ensure strong integration of interventional systems effectively.

ASIA-PACIFIC

Asia-Pacific is the fastest-growing region, holding 22% of the interventional radiology market share. China and India together account for more than 3 million angioplasty and angiography procedures annually, driven by a combined cardiovascular disease population exceeding 300 million. Japan leads in technology adoption, with more than 7,000 MRI units and advanced hybrid imaging centers. India is witnessing rapid growth, with balloon angioplasty cases exceeding 250,000 annually due to rising coronary artery disease. Reports show that nearly 68% of rural hospitals in Asia rely on ultrasound imaging due to affordability and portability.

The Asia interventional radiology market is valued at USD 7.9 billion, representing 28% share, growing at a CAGR of 7.2%. The region’s rapid expansion is supported by rising cardiovascular cases, hospital reforms, growing oncology prevalence, and increased access to advanced imaging across urban and semi-urban centers.

Top 5 Major Dominant Countries in the Asia Interventional Radiology Market

• China: Market size USD 2.8 billion, 35% share, CAGR 7.3%. Strong healthcare reforms, cardiovascular treatment initiatives, and oncology detection programs drive China’s adoption. Domestic production and hospital modernization sustain long-term growth effectively.
• Japan: Market size USD 2.0 billion, 25% share, CAGR 7.0%. An aging population, oncology expansion, and advanced medical innovations support steady demand. Japan remains a hub for advanced catheter-based imaging solutions significantly.
• India: Market size USD 1.5 billion, 19% share, CAGR 7.4%. Hospital modernization, affordability reforms, and high cardiovascular burdens drive demand. India also benefits from increasing medical tourism supporting interventional radiology expansion effectively.
• South Korea: Market size USD 900 million, 11% share, CAGR 7.1%. Innovative healthcare networks, advanced oncology treatment programs, and widespread adoption of digital diagnostics sustain South Korea’s growth momentum strongly.
• Taiwan: Market size USD 750 million, 10% share, CAGR 7.0%. Growth is supported by expanding medical infrastructure, adoption of advanced imaging technologies, and oncology treatments. Taiwan’s strong integration of AI solutions further accelerates adoption steadily.

MIDDLE EAST & AFRICA

The Middle East & Africa hold 12% of the global market share, with adoption gradually expanding due to improved healthcare infrastructure. Saudi Arabia and the UAE lead the region, together performing nearly 500,000 interventional radiology procedures annually. South Africa contributes significantly in oncology, with 60% of cancer patients requiring interventional imaging support. Reports show that cardiovascular diseases affect nearly 25% of the adult population in the Middle East, driving demand for balloon angioplasty and angiography procedures. 

The Middle East and Africa interventional radiology market is valued at USD 3.2 billion, accounting for a 12% global share, with a CAGR of 6.6%. Growth is supported by expanding hospital networks, cardiovascular disease prevalence, oncology treatment programs, and government-backed healthcare modernization initiatives.

Top 5 Major Dominant Countries in the Middle East and Africa Interventional Radiology Market

• Saudi Arabia: Market size USD 1.0 billion, 31% share, CAGR 6.8%. Growth is driven by strong hospital modernization, cardiovascular disease burden, and oncology interventions. Government-backed healthcare reforms expand adoption nationwide significantly.
• United Arab Emirates: Market size USD 850 million, 27% share, CAGR 6.7%. UAE leverages smart-health initiatives, oncology investments, and cardiovascular procedures. Its modern healthcare systems sustain interventional radiology adoption effectively.
• South Africa: Market size USD 600 million, 19% share, CAGR 6.6%. Oncology prevalence, cardiovascular cases, and hospital expansion drive demand. Public-private healthcare partnerships foster market resilience consistently.
• Egypt: Market size USD 450 million, 14% share, CAGR 6.5%. Adoption is driven by oncology programs, cardiology expansion, and hospital modernization efforts. Egypt’s urban healthcare hubs anchor demand growth steadily.
• Qatar: Market size USD 300 million, 9% share, CAGR 6.4%. Healthcare infrastructure expansion, cancer screening, and cardiovascular procedures drive growth. Qatar’s strategic health reforms sustain long-term adoption significantly.

List of Top Interventional Radiology Companies

• Toshiba Medical Systems Corporation
• Siemens AG
• Esaote S.P.A.
• Hitachi Medical Corporation
• Hologic Inc.
• Carestream Health
• Koninklijke Philips N.V.
• Shimadzu Corporation
• GE Healthcare

Top Two Companies with Highest Market Share

• Toshiba Medical Systems Corporation: Toshiba has been a global leader in diagnostic imaging, offering advanced CT, MRI, and ultrasound systems widely adopted in interventional radiology. With more than 45,000 imaging systems installed worldwide, Toshiba supports over 2 million procedures annually across oncology and cardiology.
• Siemens AG: Siemens dominates the interventional radiology market with its cutting-edge angiography systems and robotic-assisted solutions. With over 60% of European hospitals utilizing Siemens’ imaging technology, the company plays a major role in advancing minimally invasive care.

Investment Analysis and Opportunities

The interventional radiology market is witnessing strong investment momentum, with more than USD 25 billion allocated globally toward imaging infrastructure between 2024 and 2030. Reports indicate that 48% of investments are directed toward AI-powered imaging, while 37% target robotic-assisted platforms. Healthcare reforms in North America and Europe account for nearly 55% of total investments, supporting modernization of hospitals and diagnostic centers. In Asia-Pacific, China has committed over USD 200 billion in healthcare upgrades by 2030, creating massive opportunities for imaging manufacturers. Data shows that more than 1,500 clinical trials are underway worldwide, with 60% focused on oncology-related interventions.

New Product Development

Product innovation is accelerating in the interventional radiology market, with over 300 new devices launched globally in the past three years. Reports highlight that 45% of these products are AI-assisted imaging platforms, enabling radiologists to improve diagnostic accuracy by 30% and reduce reporting time by 40%. Robotic-assisted angiography systems are emerging as a major breakthrough, with adoption growing by 47% since 2020. Drug-coated balloons and bioresorbable stents have also gained traction, reducing restenosis rates by up to 45% in cardiovascular treatments. Portable imaging systems represent another area of innovation, with more than 350,000 units installed globally in 2024, widening access in rural and semi-urban hospitals.

Five Recent Developments

• In 2023, Siemens launched its AI-powered angiography system across 300 hospitals in Europe, improving diagnostic accuracy by 25%.
• GE Healthcare introduced a portable ultrasound platform in 2024, now installed in more than 1,000 rural hospitals worldwide.
• Toshiba Medical Systems expanded its hybrid CT solutions in Japan in 2024, enabling 40% faster image acquisition for cardiovascular cases.
• Philips launched its robotic-assisted navigation platform in 2023, currently adopted by 450 healthcare centers globally.
• Shimadzu Corporation introduced its 3D angiography suite in 2024, enhancing real-time vascular imaging and reducing procedure times by 28%.

Report Coverage of Interventional Radiology Market

The interventional radiology market report provides a comprehensive analysis of trends, growth drivers, restraints, and future opportunities between 2024 and 2033. Global data highlights that more than 30 million minimally invasive procedures are performed annually, with cardiovascular and oncology cases accounting for over 65% of total adoption. Reports show that by 2027, AI-driven imaging platforms will be integrated into 55% of hospitals globally, improving diagnostic efficiency by 30%. By 2030, robotic-assisted procedures are expected to represent 40% of interventional radiology applications, ensuring safer and more precise patient care. Between 2024 and 2033, over 1,500 clinical trials will test new devices and techniques, with 60% focusing on oncology and vascular disorders.

Interventional Radiology Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 25074.03 Million in 2026
Market Size Value By	USD 73308.09 Million by 2035
Growth Rate	CAGR of 12.66% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : MRI Systems Ultrasound Imaging Systems CT Scanners Angiography Systems Fluoroscopy Systems Biopsy Devices Others By Application : Angiography Balloon Angioplasty Embolization Biopsy Vertebroplasty-Kyphoplasty RF Ablation
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample